FPHFisher & Paykel Healthcare Corporation Limited

FPH Stock Price, Valuation & Chart | Fisher & Paykel Healthcare Corporation Limited

$36.310+0.57 (+1.59%)

At close · 21 Aug 2026, 06:13 am

Sector: Healthcare Industry: Medical - Instruments & Supplies FPH intrinsic value Is FPH overvalued or undervalued Website

Overview Financials Dividends Ratios

FPH Historical price chart

FPH Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization21.32B

PE Ratio53.9

EPS0.67

Trading Volume497.60K

Today's High/Low36.59/35.53

Dividend Yield1.55

52 Week High/Low36.59/26.51

Shares Outstanding587.29M

FPH Financial Statement

FPH Analyst ratings

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Based on 9 analysts giving stock ratings to FPH in the past 3 months.

FPH Analysis & performance metrics

FPH Company profile

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It…

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal…

FPH Management team

Name

Position

Justin Callahan

Vice President of Sales & Marketing and President of North America & Europe

Jonathan Rhodes

Vice President of Supply Chain, Facilities & Sustainability

Andrew Somervell

Vice President of Products & Technology

Andy NiccolCOO

Chief Operating Officer & GM of Respiratory Humidification

Daniel Adolph

Senior Communications & Investor Relations Manager

Lewis G. GradonCEO

MD, Chief Executive Officer & Executive Director

Lyndal YorkCFO

Chief Financial Officer

Hayden Brown

Head of Capital Markets & Investor Relations

Name

Position

Justin Callahan

Vice President of Sales & Marketing and President of North America & Europe

Jonathan Rhodes

Vice President of Supply Chain, Facilities & Sustainability

Andrew Somervell

Vice President of Products & Technology

Andy NiccolCOO

Chief Operating Officer & GM of Respiratory Humidification

Daniel Adolph

Senior Communications & Investor Relations Manager

Lewis G. GradonCEO

MD, Chief Executive Officer & Executive Director

Lyndal YorkCFO

Chief Financial Officer

Hayden Brown

Head of Capital Markets & Investor Relations

Management Team

Justin Callahan

Vice President of Sales & Marketing and President of North America & Europe

Jonathan Rhodes

Vice President of Supply Chain, Facilities & Sustainability

Andrew Somervell

Vice President of Products & Technology

Andy NiccolCOO

Chief Operating Officer & GM of Respiratory Humidification

Daniel Adolph

Senior Communications & Investor Relations Manager

Lewis G. GradonCEO

MD, Chief Executive Officer & Executive Director

Lyndal YorkCFO

Chief Financial Officer

Hayden Brown

Head of Capital Markets & Investor Relations

Management

Justin Callahan

Vice President of Sales & Marketing and President of North America & Europe

Jonathan Rhodes

Vice President of Supply Chain, Facilities & Sustainability

Andrew Somervell

Vice President of Products & Technology

Andy NiccolCOO

Chief Operating Officer & GM of Respiratory Humidification

Daniel Adolph

Senior Communications & Investor Relations Manager

Lewis G. GradonCEO

MD, Chief Executive Officer & Executive Director

Lyndal YorkCFO

Chief Financial Officer

Hayden Brown

Head of Capital Markets & Investor Relations

Total 8 executives

FPH Frequently asked questions

What is Fisher & Paykel Healthcare Corporation Limited (FPH) Stock Price?

Current stock price of Fisher & Paykel Healthcare Corporation Limited (FPH) stock is $36.310. The stock price is +1.59% higher in the session. The intraday range can be seen from this page. Volume of Fisher & Paykel Healthcare Corporation Limited (FPH) stock is 497.60K.

Last updated at 21 Aug 2026, 06:13 am.

Why is the Fisher & Paykel Healthcare Corporation Limited (FPH) stock price going up or down today?

The stock price of Fisher & Paykel Healthcare Corporation Limited (FPH) can change with earnings, company news, and overall market sentiment. Fisher & Paykel Healthcare Corporation Limited operates in the Healthcare / Medical - Instruments & Supplies market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Fisher & Paykel Healthcare Corporation Limited stock expensive at its current price?

Whether Fisher & Paykel Healthcare Corporation Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for FPH on this page is 53.90. EPS on this page is 0.67. Compare those figures with peers and growth expectations before deciding if the current Fisher & Paykel Healthcare Corporation Limited price is justified.

How has the stock price of Fisher & Paykel Healthcare Corporation Limited (FPH) performed historically?

Historical performance for Fisher & Paykel Healthcare Corporation Limited (FPH) is shown on the price chart on this page. Review multi-period moves alongside volume to see how FPH reacted to past earnings and market events.

Should I buy Fisher & Paykel Healthcare Corporation Limited (FPH) stock, at this price?

Buying Fisher & Paykel Healthcare Corporation Limited (FPH) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.